HUE054315T2 - Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof - Google Patents

Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof

Info

Publication number
HUE054315T2
HUE054315T2 HUE14837858A HUE14837858A HUE054315T2 HU E054315 T2 HUE054315 T2 HU E054315T2 HU E14837858 A HUE14837858 A HU E14837858A HU E14837858 A HUE14837858 A HU E14837858A HU E054315 T2 HUE054315 T2 HU E054315T2
Authority
HU
Hungary
Prior art keywords
binding
specific monovalent
monovalent diabodies
uses therof
therof
Prior art date
Application number
HUE14837858A
Other languages
Hungarian (hu)
Inventor
Ezio Bonvini
Leslie S Johnson
Ling Huang
Paul A Moore
Gurunadh Reddy Chichili
Ralph Froman Alderson
Original Assignee
Macrogenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65632998&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE054315(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP13198784.4A external-priority patent/EP2839842A1/en
Application filed by Macrogenics Inc filed Critical Macrogenics Inc
Publication of HUE054315T2 publication Critical patent/HUE054315T2/en

Links

HUE14837858A 2013-08-23 2014-08-20 Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof HUE054315T2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361869510P 2013-08-23 2013-08-23
US201361907749P 2013-11-22 2013-11-22
EP13198784.4A EP2839842A1 (en) 2013-08-23 2013-12-20 Bi-specific monovalent diabodies that are capable of binding CD123 and CD3 and uses thereof
US201461990475P 2014-05-08 2014-05-08

Publications (1)

Publication Number Publication Date
HUE054315T2 true HUE054315T2 (en) 2021-08-30

Family

ID=65632998

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14837858A HUE054315T2 (en) 2013-08-23 2014-08-20 Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof

Country Status (9)

Country Link
CL (1) CL2016000362A1 (en)
DK (1) DK3035965T3 (en)
ES (1) ES2860973T3 (en)
GE (1) GEP20197053B (en)
HK (1) HK1225999A1 (en)
HR (1) HRP20210215T1 (en)
HU (1) HUE054315T2 (en)
LT (1) LT3035965T (en)
UA (1) UA119539C2 (en)

Also Published As

Publication number Publication date
DK3035965T3 (en) 2021-02-15
HRP20210215T1 (en) 2021-04-16
CL2016000362A1 (en) 2016-10-28
GEP20197053B (en) 2019-12-25
LT3035965T (en) 2021-04-12
ES2860973T3 (en) 2021-10-05
UA119539C2 (en) 2019-07-10
HK1225999A1 (en) 2017-09-22
NZ716914A (en) 2021-09-24

Similar Documents

Publication Publication Date Title
IL244237B (en) Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof
IL251377B (en) Bi-specific monovalent diabodies that are capable of binding cd19 and cd3, and uses thereof
HK1226000A1 (en) Bi-specific monovalent diabodies that are capable of binding to gpa33 and cd3, and uses thereof
HK1249423A1 (en) Bispecific monovalent diabodies that are capable of binding b7-h3 and cd3, and uses thereof
IL244009A0 (en) Bi-specific monovalent fc diabodies that are capable of binding cd32b and cd79b and uses thereof
ZA201701341B (en) Bispecific her2 and cd3 binding molecules
IL248007A0 (en) Bispecific antibodies that bind to cd38 and cd3
IL247590A0 (en) Bi-specific antibodies and uses thereof
HK1225999A1 (en) Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses thereof
TH1601000783A (en) Bi-specific monovalent diabodies capable of binding CD123 and CD3, and their uses